What if medical abortion becomes the main or only method of first-trimester abortion? A roundtable of views
Contraception
.
2018 Feb;97(2):82-85.
doi: 10.1016/j.contraception.2017.04.004.
Epub 2017 Aug 3.
Authors
Kevin Sunde Oppegaard
1
,
Margaret Sparrow
2
,
Paul Hyland
3
,
Francisca García
4
,
Cristina Villarreal
5
,
Aníbal Faúndes
6
,
Laura Miranda
7
,
Marge Berer
8
Affiliations
1
Finnmarkssykehuset HF, Klinikk Hammerfest, Sykehusveien 35, 9601, Hammerfest, Norway. Electronic address: kevinsunde@hotmail.com.
2
Abortion Law Reform Association of New Zealand (ALRANZ), Director, Istar Limited, PO, Box 28008, Wellington 6150, New Zealand. Electronic address: msparrow@value.net.nz.
3
The Tabbot Foundation, GPO Box 3904, Sydney, NSW 2001. Australia. Electronic address: info@tabbot.com.au.
4
Asociación de Clínicas Acreditadas para la Interrupción del Embarazo (ACAI), Madrid, Spain. Electronic address: prensa@acaive.com.
5
Fundación Oriéntame & Fundación Educación para la Salud Reproductiva (ESAR), Carrera 18 # 33 A - 27, Bogotá, Colombia. Electronic address: cvillarreal@orientame.org.co.
6
Center for Research on Human Reproduction of Campinas, Campinas, SP, Brazil. Electronic address: afaundes@uol.com.br.
7
AMASS Clinic, San Cristobal de las Casas, Mexico. Electronic address: miranda.laura88@gmail.com.
8
International Campaign for Women's Right to Safe Abortion, London, UK. Electronic address: marge@margeberer.com.
PMID:
28780242
DOI:
10.1016/j.contraception.2017.04.004
No abstract available
MeSH terms
Abortifacient Agents / therapeutic use*
Abortion, Induced / methods
Abortion, Induced / psychology*
Attitude to Health
Female
Humans
Pregnancy
Pregnancy Trimester, First / psychology*
Substances
Abortifacient Agents